Active ingredientCladribineCat. No. P-C180-001CAS 4291-63-8Family · Pharmaceutical analytical standards
Cladribine
A synthetic analogue of deoxyadenosine, studied as a medicine in the 1980s by Ernest Beutler and Dennis Carson at the Scripps Research Institute in California. Approved in the United States in the early 1990s for hairy cell leukaemia, since 2017 it has also been used in Europe for relapsing multiple sclerosis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?The secret is a single chlorine atom at position 2: it makes the molecule more resistant to adenosine deaminase, the enzyme that would quickly break down natural deoxyadenosine, so the drug can act on lymphocytes for a long time.
Go to the active ingredient →Active ingredientCladribineCat. No. P-C180-001CAS 4291-63-8
Active ingredientCladribine PhosphateCat. No. P-C180-002
Pharmacopoeial impurityCladribine EP Impurity ACat. No. P-C180-003CAS 4546-70-7
Pharmacopoeial impurityCladribine EP Impurity BCat. No. P-C180-004CAS 24757-70-8
Pharmacopoeial impurityCladribine EP Impurity CCat. No. P-C180-005CAS 1839-18-5
Pharmacopoeial impurityCladribine EP Impurity DCat. No. P-C180-006CAS 5542-92-7
Pharmacopoeial impurityCladribine EP Impurity FCat. No. P-C180-007CAS 619-55-6
Pharmacopoeial impurityCladribine EP Impurity GCat. No. P-C180-008CAS 99-75-2
Isotopically labelledCladribine-13C-15N2Cat. No. P-C180-009
Impurity2-Deoxy-d-ribofuranoseCat. No. P-C180-010CAS 533-67-5
Impurity5'-(3-MAL-PEG2-aminobutanoate)-cladribineCat. No. P-C180-011
ImpurityCladribine Mono Benzoate ImpurityCat. No. P-C180-012CAS 152463-98-4
ImpurityDeoxyribofuranosyl chlorideCat. No. P-C180-013CAS 80184-05-0No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceCladribine CRSEDQM code Y0000639Family CladribineImpurityCladribine impurity C CRSEDQM code Y0000610Family CladribineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.